Magic mushroom compound psilocybin shows ‘promise’ in depression
Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting
Read More
Tag: depression
Janssen disappointed with second NICE no for Spravato
NICE has concerns with the evidence submitted but Janssen insists the nasal spray is a cost-effective use of NHS resources
Read More
Janssen submits Spravato expansion in EU
The J&J division seeks to expand the use to adults with major depressive disorder who have current suicidal ideation with intent.
Read More
Sertraline improves anxiety, but ‘unlikely’ to treat depression
The findings support the prescription of SSRI antidepressants in a wider group of participants than previously thought.
Read More
White matter affects response to brain stimulation therapy
The team ultimately found that “people with stronger white matter connections in their brain had better improvement with stimulation.”
Read More
Neuraxpharm launches first products in UK
It has also announced the appointment of the company’s new general manager, Craig Bowen.
Read More
NICE issues guidance revision for depression
The governing body has been urged to undergo a “full and proper revision” of its 2009 guideline on adult depression.
Read More
Allergan’s rapastinel fails to hit key targets in depression trials
Allergan’s rapastinel has failed to hit its primary endpoints in three late-stage studies assessing its potential as an adjunctive treatment for depression.
Read More
FDA approves nasal spray for treatment-resistant depression
The FDA has approved Johnson & Johnson’s Spravato for treatment-resistant depression, offering patients the first new treatment option in several years.
Read More
Spravato gets FDA Advisory Committee approval
FDA advisory committees have jointly voted in favour of approving Janssen’s Spravato nasal spray CIII for adults living with treatment-resistant depression.
Read More
Study says ‘Older people need better access to psychological therapies’
A new study has found that 10% of adults aged over 75 have major depressive disorder, and over one third sub-threshold depressive symptoms.
Read More
Scottish researchers link 100 variants and 269 genes to depression
More than 100 independent variants and 269 genes have been linked to depression by scientists in Edinburgh.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
